Ascendis Pharma
ASND
#1544
Rank
โ‚น1.256 T
Marketcap
โ‚น20,460
Share price
-1.65%
Change (1 day)
51.17%
Change (1 year)

Revenue for Ascendis Pharma (ASND)

Revenue in 2025 (TTM): โ‚น73.67 Billion

According to Ascendis Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚น78.93 Billion. an increase over the revenue in the year 2024 that were of โ‚น33.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ascendis Pharma from 2014 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น75.13 B126.01%
2024 โ‚น33.24 B37.09%
2023 โ‚น24.24 B447.4%
2022 โ‚น4.42 B567.18%
2021 โ‚น0.66 B14.09%
2020 โ‚น0.58 B-45.52%
2019 โ‚น1.06 B26.17%
2018 โ‚น0.84 B657.64%
2017 โ‚น0.11 B-67.76%
2016 โ‚น0.34 B-41.56%
2015 โ‚น0.59 B-49.14%
2014 โ‚น1.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Akebia Therapeutics
AKBA
โ‚น21.22 B-73.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚น90.7 M-99.89%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
โ‚น10.75 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA